2013Shanxi Yike Daxue xuebaoRequires access

Molecular biological markers expression in breast cancer and its relationship with clinicopathological features

Xianming Wang

Open publisher page 0 citations

Abstract

Objective To investigate the expression of estrogen receptor,progesterone receptor,HER-2,Ki-67 in breast cancer and their clinical significance.Methods The expression of ER,PR,HER-2 and Ki-67 was detected in 372 patients with breast cancer and their correlations with clinicopathological features were analyzed.Results ER,PR positive expression rates were significantly lower in patients with lymph node metastasis than those in patients with no lymph node metastasis(P0.05),while HER-2 and Ki-67 positive expression rates were higher(P0.05).ER,PR positive expression rates were lower in patients with tumor size20 mm than those in patients with tumor size20 mm(P0.05),while HER-2 and Ki-67 positive expression rates were higher(P0.05).Expression of ER,PR was negatively correlated with HER-2,Ki-67 expression(P0.05).Conclusion ER,PR and HER-2,Ki-67 are valuable for predicting the breast cancer prognosis and providing the individualized treatment.

About this research paper

What this paper is about

Objective To investigate the expression of estrogen receptor,progesterone receptor,HER-2,Ki-67 in breast cancer and their clinical significance.Methods The expression of ER,PR,HER-2 and Ki-67 was detected in 372 patients with breast cancer and their correlations with clinicopathological features were analyzed.Results ER,PR positive expression rates were significantly lower in patients with lymph node metastasis than those in patients with no lymph node metastasis(P0.05),while HER-2 and Ki-67 positive expression rates were higher(P0.05).ER,PR positive expression rates were lower in patients with tumor size20 mm than those in patients with tumor size20 mm(P0.05),while HER-2 and Ki-67 positive expression rates were higher(P0.05).Expression of ER,PR was negatively correlated with HER-2,Ki-67 expression(P0.05).Conclusion ER,PR and HER-2,Ki-67 are valuable for predicting the breast cancer prognosis and providing the individualized treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the expression of estrogen receptor,progesterone receptor,HER-2,Ki-67 in breast cancer and their clinical significance.Methods The expression of ER,PR,HER-2 and Ki-67 was detected in 372 patients with breast cancer and their correlations with clinicopathological features were analyzed.Results ER,PR positive expression rates were significantly lower in patients with lymph node metastasis than those in patients with no lymph node metastasis(P0.05),while HER-2 and Ki-67 positive expression rates were higher(P0.05).ER,PR positive expression rates were lower in patients with tumor size20 mm than those in patients with tumor size20 mm(P0.05),while HER-2 and Ki-67 positive expression rates were higher(P0.05).Expression of ER,PR was negatively correlated with HER-2,Ki-67 expression(P0.05).Conclusion ER,PR and HER-2,Ki-67 are valuable for predicting the breast cancer prognosis and providing the individualized treatment.

Key concepts: Breast cancer, Estrogen receptor, Medicine, Progesterone receptor, Ki-67, Lymph node metastasis, Internal medicine, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
Molecular biological markers expression in breast cancer and its relationship with clinicopathological features — Research Paper | ScholarLens